SVB Leerink Upgrades Elevance Health to Outperform, Raises Price Target to $580

SVB Leerink analyst Whit Mayo upgrades Elevance Health (NYSE:ELV) from Market Perform to Outperform and raises the price target from $490 to $580.

SVB Leerink analyst Whit Mayo upgrades Elevance Health (NYSE:ELV) from Market Perform to Outperform and raises the price target from $490 to $580.

Total
0
Shares
Related Posts